Reply

Affiliations

¹ Diakonhjemmet Hospital and University of Oslo.
² Diakonhjemmet Hospital, Oslo, Norway.
³ Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

Comment

Vibeke Norvang et al. Arthritis Rheumatol. 2020 Aug.

. 2020 Aug;72(8):1407-1408.

doi: 10.1002/art.41268. Epub 2020 Jun 10.

¹ Diakonhjemmet Hospital and University of Oslo.
² Diakonhjemmet Hospital, Oslo, Norway.
³ Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

No abstract available

Comment on

Achievement of remission in two early rheumatoid arthritis cohorts implementing different treat-to-target strategies.
Norvang V, Brinkmann GH, Yoshida K, Lillegraven S, Aga AB, Sexton J, Tedeschi SK, Lyu H, Norli ES, Uhlig T, Kvien TK, Mjaavatten MD, Solomon DH, Haavardsholm EA; ARCTIC study group; NOR-VEAC study group. Norvang V, et al. Arthritis Rheumatol. 2020 Feb 23. doi: 10.1002/art.41232. Online ahead of print. Arthritis Rheumatol. 2020. PMID: 32090491
Classifying Remission in Rheumatoid Arthritis Treat-to-Target Studies: Comment on the Article by Norvang et al.
Xie W, Zhang Z. Xie W, et al. Arthritis Rheumatol. 2020 Aug;72(8):1406-1407. doi: 10.1002/art.41269. Epub 2020 Jun 12. Arthritis Rheumatol. 2020. PMID: 32249529 No abstract available.